These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9069790)

  • 21. Redesigning peritoneal dialysis catheter exit-site classification.
    Cho P; Exconde E; Sulit V; Brunier G; Espiritu A; Taruc E; Drayton S
    CANNT J; 2012; 22(1):39-41. PubMed ID: 22558682
    [No Abstract]   [Full Text] [Related]  

  • 22. Swimming on Peritoneal Dialysis: Recommendations from Australian PD Units.
    Lee A
    Perit Dial Int; 2019; 39(6):527-531. PubMed ID: 31582469
    [No Abstract]   [Full Text] [Related]  

  • 23. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exit-site care--is it time for a change?
    Hasbargen BJ; Rodgers DJ; Hasbargen JA; Quinn MJ; James MK
    Perit Dial Int; 1993; 13 Suppl 2():S313-5. PubMed ID: 8399597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency of a silver ring in preventing exit-site infections in adult PD patients: results of the SIPROCE Study. Silver ring Prophylaxis of the Catheter Exit Site.
    Adv Perit Dial; 1997; 13():227-32. PubMed ID: 9360688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine.
    Fong IW
    Postgrad Med J; 1993; 69 Suppl 3():S15-7. PubMed ID: 8290450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysis catheter management practices in Australia and New Zealand.
    Smyth B; Kotwal S; Gallagher M; Gray NA; Polkinghorne K;
    Nephrology (Carlton); 2019 Aug; 24(8):827-834. PubMed ID: 30267459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of dressing protocols that reduce peritoneal dialysis catheter exit site infections.
    Jensen SR; Pomeroy M; Davidson M; Cox M; McMurray SD
    ANNA J; 1989 Oct; 16(6):425-31. PubMed ID: 2818011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exit-site/tunnel infection and catheter outcome in peritoneal dialysis patients.
    Wadhwa NK; Cabralda T; Suh H; Kvilekval K; Mason R
    Adv Perit Dial; 1992; 8():325-7. PubMed ID: 1361816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computed tomography for the management of exit-site and tunnel infections in peritoneal dialysis patients
.
    Nozaki K; Kamijo Y; Nakatsuka M; Azuma T; Nakagawa T; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Ishibashi Y; Homma Y
    Clin Nephrol; 2016 Dec; 86 (2016)(12):328-332. PubMed ID: 27805563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
    Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
    Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low sensitivity of the exit site scoring system in detecting exit site infections in peritoneal dialysis patients.
    Elamin S; Khaier ME; Kaballo BG; Abu-Aisha H
    Clin Nephrol; 2014 Feb; 81(2):100-4. PubMed ID: 24321185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of cleansing agents at the peritoneal catheter exit site.
    Wong FS
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S148-52. PubMed ID: 17986537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritoneal dialysis access-related procedures by nephrologists.
    Asif A
    Semin Dial; 2004; 17(5):398-406. PubMed ID: 15461749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of healing and external tunnel histology of silver-coated peritoneal catheters in rats.
    Kathuria P; Moore HL; Mehrotra R; Prowant BF; Khanna R; Twardowski ZJ
    Adv Perit Dial; 1996; 12():203-8. PubMed ID: 8865903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three year prospective follow up of the peritoneal access.
    Reyero A; Galera A
    EDTNA ERCA J; 1998; 24(4):32-5. PubMed ID: 10222914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol for treatment of exit-site and tunnel infections in 177 CAPD patients.
    Bianchessi S; Galimberti E; Belluschi F; Bosaglia M
    EDTNA ERCA J; 1998; 24(2):21-2, 25. PubMed ID: 10392060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.
    Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of peritoneal dialysis catheter-related infections.
    Copley JB
    Am J Kidney Dis; 1987 Dec; 10(6):401-7. PubMed ID: 3318412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.